Naproxen kinetics in synovial fluid of patients with osteoarthritis. 1988

R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
Recherche Syntex France, Leuville-sur-Orge.

1. The kinetics of naproxen in synovial fluid were studied in 407 osteoarthritic outpatients with knee effusion requiring aspiration, following a single 1100 mg oral dose of naproxen sodium. 2. The drug concentration-time profiles were described by a biexponential function. Naproxen entered synovial fluid rapidly, reaching a maximum concentration of 36 mg l-1 (Cmax) at 7.5 h. The first order input rate constant (kOs) was 0.41 +/- 0.15 h-1 with a lag time (tlag) of 0.24 +/- 0.36 h. 3. Elimination from the fluid was slow (t1/2 = 31 +/- 12 h) and appreciable drug concentrations were still measurable (27 mg l-1) after 24 h. 4. During once daily dosing of naproxen sodium, naproxen should accumulate in synovial fluid, a steady-state being achieved within a week of treatment. The predicted accumulation ratio based on trough concentration was 2.4.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D013582 Synovial Fluid The clear, viscous fluid secreted by the SYNOVIAL MEMBRANE. It contains mucin, albumin, fat, and mineral salts and serves to lubricate joints. Synovia,Fluid, Synovial,Fluids, Synovial,Synovial Fluids

Related Publications

R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
August 1995, American journal of veterinary research,
R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
May 2020, Osteoarthritis and cartilage,
R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
December 2003, Clinical rheumatology,
R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
January 1977, Scandinavian journal of rheumatology,
R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
January 2007, Modern rheumatology,
R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
May 1999, Rheumatic diseases clinics of North America,
R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
May 1985, Arthritis and rheumatism,
R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
July 2021, Cytokine,
R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
January 2015, International journal of clinical and experimental pathology,
R Bruno, and A Iliadis, and I Jullien, and M Guego, and H Pinhas, and S Cunci, and J P Cano
April 2015, Scandinavian journal of clinical and laboratory investigation,
Copied contents to your clipboard!